A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2011
12/29/2011	US20110318421 Surface functionalized ceramic nanoparticles
12/29/2011	US20110318420 Fulvestrant nanosphere/microsphere and preparative method and use thereof
12/29/2011	US20110318419 Graft materials containing bioactive substances, and methods for their manufacture
12/29/2011	US20110318418 Compositions of 5-ethyl-2--pyrimidine
12/29/2011	US20110318417 Highly pure cinacalcet or a pharmaceutically acceptable salt thereof
12/29/2011	US20110318416 Bioresorbable polymer matrices and methods of making and using the same
12/29/2011	US20110318415 Hollow Gold Nanospheres (HAuNSs) and HAuNSs-Loaded Microspheres Useful in Drug Delivery
12/29/2011	US20110318413 Extended release formulations containing darifenacin or pharmaceutically acceptable salts thereof
12/29/2011	US20110318412 Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
12/29/2011	US20110318411 Multi-layered orally disintegrating tablet and the manufacture thereof
12/29/2011	US20110318410 Rare earth metal compounds, methods of making, and methods of using the same
12/29/2011	US20110318409 Fractions of wheat germ ferment
12/29/2011	US20110318408 Hla class i a2 tumor associated antigen peptides and vaccine compositions
12/29/2011	US20110318407 Inactivated dengue virus vaccine with aluminium-free adjuvant
12/29/2011	US20110318406 Lecithin carrier vesicles and methods of making the same
12/29/2011	US20110318405 Chemical Combination and Method for Increasing Delivery of Coenzyme Q10
12/29/2011	US20110318404 Wound Dressing, Methods and Apparatus For Making Same and Storage and Use Thereof
12/29/2011	US20110318403 Preparation and Use of Pouteria Lucuma Extract
12/29/2011	US20110318402 Tricalcium phosphates, their composites, implants incorporating them, and methods for their production
12/29/2011	US20110318401 Treatment of leg ulcers using placenta derived collagen biofabric
12/29/2011	US20110318400 Skin Care Product
12/29/2011	US20110318396 Dermatological/cosmetic compositions comprising a retinoid and benzoyl peroxide
12/29/2011	US20110318395 Polyhydroxyalkanoate medical textiles and fibers
12/29/2011	US20110318394 Multi-linked star-shaped polymers and synthetic methods therfor
12/29/2011	US20110318393 Substituted Pyrazole Compounds
12/29/2011	US20110318392 Drug coating providing high drug loading and methods for providing the same
12/29/2011	US20110318391 Bioactive Dose Having Containing a Material for Modulating pH of a Bodily Fluid to Help or Hinder Absorption of a Bioactive
12/29/2011	US20110318390 Bioactive Dose Having a Rapid Release Coating or Rapid Release Layer Containing a Material for Modulating pH of a Bodily Fluid to Help or Hinder Absorption of a Bioactive
12/29/2011	US20110318389 Human pancreatic beta cell lines for diagnostic of diabetes
12/29/2011	US20110318343 Stable Liquid Pharmaceutical Formulation Of IgG Antibodies
12/29/2011	US20110318278 Foamable suspension gel
12/29/2011	US20110318277 Tacrolimus compositions for aerosol administration
12/29/2011	US20110318275 Multifunctional contrast agent using biocompatible polymer and preparation method
12/29/2011	US20110318267 Ph-responsive nanostructures
12/29/2011	DE102010032149A1 Nano-Hydrogele für die therapeutische und nichttherapeutische Behandlung, insbesondere zur Therapie von Stresszuständen und Regeneration geschädigter Zellsysteme (Nano-Shuttle-System) Nano-hydrogels for the therapeutic and non-therapeutic treatment, in particular for the treatment of stress conditions and regeneration of damaged cell systems (nano-shuttle system)
12/29/2011	CA2840339A1 Lecithin carrier vesicles and methods of making the same
12/29/2011	CA2835151A1 Method of treatment
12/29/2011	CA2806162A1 Composition and method of treating lipid encapsulated virus infections
12/29/2011	CA2805413A1 Methods and compositions for cns delivery of heparan n-sulfatase
12/29/2011	CA2803770A1 Process for producing emulsifier-producing material, process for producing emulsifier, emulsifier for orally administered composition, and orally administered composition
12/29/2011	CA2803458A1 Dialysis precursor composition
12/29/2011	CA2803432A1 Dialysis precursor composition
12/29/2011	CA2803418A1 Dry powder formulation comprising an antimuscarinic drug
12/29/2011	CA2803258A1 Pharmaceutical composition comprising midazolam
12/29/2011	CA2802932A1 Long-term storage of non-glycosylated recombinant human g-csf
12/29/2011	CA2802764A1 Method of producing pharmacologically pure crystals
12/29/2011	CA2802756A1 Compositions and methods for stabilizing protein-containing formulations
12/29/2011	CA2802604A1 Taste-masked pharmaceutical formulation having accelerated onset of action
12/29/2011	CA2802541A1 Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
12/29/2011	CA2802335A1 Controlled release compositions with reduced food effect
12/29/2011	CA2802209A1 Sustained-release formulation
12/29/2011	CA2801731A1 Topical ophthalmic suspensions containing tobramycin and dexamethasone
12/29/2011	CA2801098A1 Tolvaptan solid dispersion and its preparation method
12/29/2011	CA2800475A1 Therapeutic oral compositions
12/29/2011	CA2798019A1 Stabilized active compound
12/28/2011	EP2399742A1 Antimicrobial hand towel for touchless automatic dispensers
12/28/2011	EP2399658A1 Method for producing pharmacologically pure crystals
12/28/2011	EP2399648A2 Cosmetic composition and use of same
12/28/2011	EP2399608A1 Immunomodulating nanoparticulate composition for use in inhalation therapy
12/28/2011	EP2399607A1 Transdermal preparation
12/28/2011	EP2399587A1 Liposome treatment of viral infections
12/28/2011	EP2399581A1 Drug detoxification protocol using microdosing
12/28/2011	EP2399580A1 Pharmaceutical dosage forms
12/28/2011	EP2399579A1 Pharmaceutical dosage forms
12/28/2011	EP2399574A1 Intraoral film-like base agent and formulation
12/28/2011	EP2399573A1 Compositions comprising poorly water soluble pharmaceutical agents
12/28/2011	EP2399572A1 Long-term storage of non-glycosylated recombinant human G-CSF
12/28/2011	EP2399571A1 Therapeutic compositions comprising ingenol-3-angelate
12/28/2011	EP2398845A1 Amphiphilic compounds and self-assembling compositions made therefrom
12/28/2011	EP2398512A2 Functionalized adhesive medical gel
12/28/2011	EP2398499A1 Bi-functional co-polymer use for ophthalmic and other topical and local applications
12/28/2011	EP2398476A1 Policosanol nanoparticles
12/28/2011	EP2398470A1 Controlled-release compositions comprising a proton pump inhibitor
12/28/2011	EP2398469A1 Controlled release compositions comprising anti-cholinergic drugs
12/28/2011	EP2398468A1 Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation
12/28/2011	EP2398467A1 Particles comprising drospirenone encapsulated in a polymer
12/28/2011	EP2398466A2 Methods and compositions for localized agent delivery
12/28/2011	EP2398465A1 A dermaceutical gel made using sodium fusidate&a process to make it
12/28/2011	EP2398464A2 Pharmaceutical composition for inhalation
12/28/2011	EP2398463A1 A method for amphiphilic drug loading in liposomes by ion gradient
12/28/2011	EP2398462A1 Ph-modulated formulations for pulmonary delivery
12/28/2011	EP2398461A1 Formulation comprising drospirenone for subcutaneous or intramuscular administration
12/28/2011	EP2398460A2 Particle size-structured parenteral dispersions
12/28/2011	EP2398459A2 Transdermal delivery of diclofenac, carbamazepine and benzydamine
12/28/2011	EP2398458A1 Pharmaceutical composition containing microcolloidal silver and carboxymethyl beta glucan for disinfection of the nasal mucosae, and process for preparation thereof
12/28/2011	EP2398457A2 A topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
12/28/2011	EP2398443A2 Storage stable prostaglandin product
12/28/2011	EP2315580B1 Pharmaceutical formulations and methods for treating respiratory tract infections
12/28/2011	EP2257275B1 Ketorolac tromethamine compositions for treating or preventing ocular pain
12/28/2011	EP2170332B1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol
12/28/2011	EP1896025B1 Scopolamine for the treatment of depression and anxiety
12/28/2011	EP1861054B1 Methods of manufacturing a medicated tampon assembly
12/28/2011	EP1857120B1 Infusion for mastitis
12/28/2011	EP1640022B1 Menthol-containing preparation
12/28/2011	EP1596828B1 Lipophilic drug delivery vehicle and methods of use thereof
12/28/2011	EP1523303B1 Medicaments containing vardenafil hydrochloride trihydrate and processes for the manufacture thereof
12/28/2011	EP1469745B1 Use of multi-layer pigments in the food and pharmaceutical industry
12/28/2011	CN1907273B 烟碱透皮制剂的制备方法 Nicotine transdermal formulation preparation
12/28/2011	CN1774259B 治疗系统性红斑狼疮的肽的胃肠道外制剂 Parenteral preparations for treatment of systemic lupus erythematosus peptides
12/28/2011	CN1713896B 球形体、其制备方法以及药物组合物 Spherical bodies, their preparation and pharmaceutical compositions

1 ... 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 ... 2991